Terms: = Skin cancer AND FHIT, P49789, FRA3B, AP3Aase, ENSG00000189283, 2272
30 results:
1. The Robust Tumoricidal Effects of Combined BET/HDAC Inhibition in Cutaneous T-Cell Lymphoma Can Be Reproduced by ΔNp73 Depletion.
Zhao L; Hsiao T; Stonesifer C; Daniels J; Garcia-Saleem TJ; Choi J; Geskin L; Rook AH; Wood GS
J Invest Dermatol; 2022 Dec; 142(12):3253-3261.e4. PubMed ID: 35787399
[TBL] [Abstract] [Full Text] [Related]
2. [Epigenetic changes in the promoter of the fragile histidine triad (fhit) gene in human sebocytes under the influence of in vitro culture].
Jotzo M; Zouboulis CC; Ballhausen WG
Ophthalmologie; 2022 Aug; 119(8):813-819. PubMed ID: 35254487
[TBL] [Abstract] [Full Text] [Related]
3. Coexisting Conditions among Children and Adolescents with cancer in a Section of the South African Private Health Sector: Perspectives from Drug Utilization Data.
Otoo MN; Lubbe MS; Steyn H; Burger JR
J Epidemiol Glob Health; 2021 Mar; 11(1):105-116. PubMed ID: 33605112
[TBL] [Abstract] [Full Text] [Related]
4. Differences between pure desmoplastic melanoma and superficial spreading melanoma in terms of survival, distribution and other clinicopathologic features.
Howard MD; Wee E; Wolfe R; McLean CA; Kelly JW; Pan Y
J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1899-1906. PubMed ID: 31237040
[TBL] [Abstract] [Full Text] [Related]
5. Gemcitabine, dexamethasone, and cisplatin (GDP) chemotherapy with sandwiched radiotherapy in the treatment of newly diagnosed stage IE/IIE extranodal natural killer/T-cell lymphoma, nasal type.
Tian S; Li R; Wang T; Wang S; Tao R; Hu X; Ding H
Cancer Med; 2019 Jul; 8(7):3349-3358. PubMed ID: 31050212
[TBL] [Abstract] [Full Text] [Related]
6. microRNA-143 protects cells from DNA damage-induced killing by downregulating fhit expression.
Lin YX; Yu F; Gao N; Sheng JP; Qiu JZ; Hu BC
Cancer Biother Radiopharm; 2011 Jun; 26(3):365-72. PubMed ID: 21711110
[TBL] [Abstract] [Full Text] [Related]
7. Restoration of fragile histidine triad (fhit) expression inhibits cell growth and induces apoptosis in cutaneous T-cell lymphoma cell line.
Song X; Tian Z; Wang S; Peng Z; Feng J
Cancer Invest; 2010 Dec; 28(10):1019-23. PubMed ID: 20690795
[TBL] [Abstract] [Full Text] [Related]
8. Immunohistochemical fhit expression still exists in early lesions of basal cell carcinoma.
Kiyici H; Bilezikçi B; Ozen O; Demirhan B
Pathol Res Pract; 2010 Jul; 206(7):445-9. PubMed ID: 20399571
[TBL] [Abstract] [Full Text] [Related]
9. Frequent occurrence of RASSF1A promoter hypermethylation and Merkel cell polyomavirus in Merkel cell carcinoma.
Helmbold P; Lahtz C; Enk A; Herrmann-Trost P; Marsch WCh; Kutzner H; Dammann RH
Mol Carcinog; 2009 Oct; 48(10):903-9. PubMed ID: 19326371
[TBL] [Abstract] [Full Text] [Related]
10. Single nucleotide polymorphism array analysis defines a specific genetic fingerprint for well-differentiated cutaneous SCCs.
Purdie KJ; Harwood CA; Gulati A; Chaplin T; Lambert SR; Cerio R; Kelly GP; Cazier JB; Young BD; Leigh IM; Proby CM
J Invest Dermatol; 2009 Jun; 129(6):1562-8. PubMed ID: 19131950
[TBL] [Abstract] [Full Text] [Related]
11. Deletions of BRCA1/2 and p53 R248W gain-of-function mutation suggest impaired homologous recombination repair in fragile histidine triad-negative sebaceous gland carcinomas.
Becker K; Goldberg M; Helmbold P; Holbach LM; Loeffler KU; Ballhausen WG
Br J Dermatol; 2008 Dec; 159(6):1282-9. PubMed ID: 18717684
[TBL] [Abstract] [Full Text] [Related]
12. Analysis of fhit allelic imbalance/loss of heterozygosity and fhit expression in cutaneous squamous cell carcinomas.
Gray SE; Kay E; Leader M; Mabruk M
J Cutan Pathol; 2008 Sep; 35(9):816-25. PubMed ID: 18494825
[TBL] [Abstract] [Full Text] [Related]
13. Investigation of mutations and expression of the fhit gene in Turkish patients with brain metastases derived from non-small cell lung cancer.
Bekar A; Ceçener G; Tunca B; Guler G; Egeli U; Tolunay S
Tumori; 2007; 93(6):604-7. PubMed ID: 18338497
[TBL] [Abstract] [Full Text] [Related]
14. Methylation of CpG island promoters in uveal melanoma.
Moulin AP; Clément G; Bosman FT; Zografos L; Benhattar J
Br J Ophthalmol; 2008 Feb; 92(2):281-5. PubMed ID: 18211945
[TBL] [Abstract] [Full Text] [Related]
15. Epigenetic silencing contributes to frequent loss of the fragile histidine triad tumour suppressor in basal cell carcinomas.
Goldberg M; Rummelt C; Laerm A; Helmbold P; Holbach LM; Ballhausen WG
Br J Dermatol; 2006 Dec; 155(6):1154-8. PubMed ID: 17107382
[TBL] [Abstract] [Full Text] [Related]
16. Biological functions of mammalian Nit1, the counterpart of the invertebrate Nitfhit Rosetta stone protein, a possible tumor suppressor.
Semba S; Han SY; Qin HR; McCorkell KA; Iliopoulos D; Pekarsky Y; Druck T; Trapasso F; Croce CM; Huebner K
J Biol Chem; 2006 Sep; 281(38):28244-53. PubMed ID: 16864578
[TBL] [Abstract] [Full Text] [Related]
17. Different genetic pathways in the development of periocular sebaceous gland carcinomas in presumptive Muir-Torre syndrome patients.
Goldberg M; Rummelt C; Foja S; Holbach LM; Ballhausen WG
Hum Mutat; 2006 Feb; 27(2):155-62. PubMed ID: 16395674
[TBL] [Abstract] [Full Text] [Related]
18. A phase II study of biochemotherapy for advanced melanoma incorporating temozolomide, decrescendo interleukin-2 and GM-CSF.
Lewis KD; Gibbs P; O'Day S; Richards J; Weber J; Anderson C; Zeng C; Baron A; Russ P; Gonzalez R
Cancer Invest; 2005; 23(4):303-8. PubMed ID: 16100942
[TBL] [Abstract] [Full Text] [Related]
19. Loss of fragile histidine triad (fhit) expression and microsatellite instability in periocular sebaceous gland carcinoma in patients with Muir-Torre syndrome.
Holbach LM; von Moller A; Decker C; Jünemann AG; Rummelt-Hofmann C; Ballhausen WG
Am J Ophthalmol; 2002 Jul; 134(1):147-8. PubMed ID: 12095833
[TBL] [Abstract] [Full Text] [Related]
20. UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas.
Popp S; Waltering S; Herbst C; Moll I; Boukamp P
Int J Cancer; 2002 May; 99(3):352-60. PubMed ID: 11992403
[TBL] [Abstract] [Full Text] [Related]
[Next]
